Financial results - PREDA MEDSAN SRL

Financial Summary - Preda Medsan Srl
Unique identification code: 15106949
Registration number: J11/510/2002
Nace: 8621
Sales - Ron
95.135
Net Profit - Ron
66.025
Employee
The most important financial indicators for the company Preda Medsan Srl - Unique Identification Number 15106949: sales in 2023 was 95.135 euro, registering a net profit of 66.025 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Preda Medsan Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 37.089 42.767 38.452 48.135 102.705 137.961 73.612 80.163 83.960 95.135
Total Income - EUR 37.089 42.767 38.453 48.135 104.202 138.383 73.612 80.164 83.969 95.439
Total Expenses - EUR 33.313 33.039 29.325 26.646 30.183 24.401 29.988 28.424 29.446 28.459
Gross Profit/Loss - EUR 3.776 9.728 9.127 21.489 74.019 113.982 43.624 51.740 54.522 66.980
Net Profit/Loss - EUR 2.664 8.445 8.743 21.008 72.977 112.598 42.955 50.939 53.683 66.025
Employees 2 2 3 2 2 2 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 13.7%, from 83.960 euro in the year 2022, to 95.135 euro in 2023. The Net Profit increased by 12.505 euro, from 53.683 euro in 2022, to 66.025 in the last year.

Check the financial reports for the company - Preda Medsan Srl

Rating financiar

Financial Rating -
Preda Medsan Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Preda Medsan Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Preda Medsan Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Preda Medsan Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Preda Medsan Srl - CUI 15106949

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 74.604 68.372 64.364 62.685 62.280 66.482 63.563 60.605 59.284 58.098
Current Assets 6.109 11.201 10.401 25.927 55.305 129.017 55.354 39.884 88.621 68.386
Inventories 0 1.952 1.932 0 0 3.098 3.039 2.971 0 50
Receivables 1.979 2.481 3.541 3.962 12.079 5.934 10.126 6.796 6.887 14.709
Cash 4.130 6.769 4.929 21.965 43.225 119.985 42.189 30.117 81.734 53.627
Shareholders Funds 24.025 3.975 11.835 24.036 75.777 115.588 45.984 97.123 57.384 123.117
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 56.688 75.598 62.930 64.576 41.808 79.911 72.933 3.366 90.521 3.366
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 68.386 euro in 2023 which includes Inventories of 50 euro, Receivables of 14.709 euro and cash availability of 53.627 euro.
The company's Equity was valued at 123.117 euro, while total Liabilities amounted to 3.366 euro. Equity increased by 65.907 euro, from 57.384 euro in 2022, to 123.117 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Preda Medsan Srl

Comments - Preda Medsan Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.